Ticker LaunchIPO · RNLX
Renalytix plc
Formerly Renalytix AI plc
Renalytix plc (RNLX) priced its initial public offering on Jul 17, 2020 at $13.50 per ADS, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $802.1M. J.P. Morgan was lead-left underwriter, joined by Stifel. Goodwin Procter advised the underwriters.
Renalytix plc is an AI-enabled in vitro diagnostics company focused on kidney disease management. Its KidneyIntelX platform combines blood biomarkers, genetics and electronic health record data using a proprietary algorithm, and its U.S. offices are in New York.
- Status
- IPO
- Ticker
- RNLX
- Exchange
- Nasdaq Global Market
- Priced
- Jul 17, 2020
- IPO price
- $13.50 per ADS
- Market cap at IPO price
- $802.1M
- First filed
- Jun 24, 2020
- Underwriters
- J.P. Morgan and Stifel
- Underwriters' counsel
- Goodwin Procter
- Sector
- Healthcare
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Jun 24, 2020
- Latest amendment Jul 13, 2020
- Final prospectus (424B4) Jul 17, 2020
- All filings on EDGAR CIK 1811115
Other Healthcare IPOs in 2020
- Nano-X Imaging Ltd.NNOX · Aug 24, 2020
- Acutus Medical, Inc.AFIB · Aug 7, 2020 · $158.8M
- Oak Street Health, Inc.OSH · Aug 7, 2020 · $328.1M
- PolyPid Ltd.PYPD · Jun 29, 2020 · $60M
- Genetron Holdings LtdGTH · Jun 22, 2020
- Burning Rock Biotech LtdBNR · Jun 12, 2020 · $222.8M